Manipal Health Enterprises Ltd
Manipal Health Enterprises Ltd (MANIPALHOS) last reported results for the quarter ended Jun 2026, with sales of ₹3,091 crore and net profit of ₹243 crore. The stock last traded at ₹670, a market capitalisation of ₹88,084 crore, on a P/E of 99.5. Over the past 52 weeks the stock has ranged between ₹625 and ₹815. Figures are as of 6 Oct 2026 and are not real time.
Manipal Health Enterprises Ltd share price and key metrics
- Current price
- ₹670
- Market cap
- ₹88,084 cr
- Stock P/E
- 99.5
- ROE
- 12.7%
- ROCE
- 12.1%
- Dividend yield
- 0.00%
- 52w high / low
- 815/625
Metrics as of 6 Oct 2026. Not real time.
Track Manipal Health Enterprises Ltd
Cruxal reads every Manipal Health Enterprises Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Manipal Health Enterprises Ltd growth and returns
- 10 Years
- %
- 5 Years
- 42%
- 3 Years
- 29%
- TTM
- 25%
- 10 Years
- %
- 5 Years
- 77%
- 3 Years
- 22%
- TTM
- -10%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- %
- 10 Years
- %
- 5 Years
- 16%
- 3 Years
- 17%
- Last Year
- 13%
Manipal Health Enterprises Ltd quarterly results
| ₹ crore | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Sales | 2,238 | 2,882 | 3,091 |
| Expenses | 1,651 | 2,191 | 2,354 |
| Operating profit | 586 | 691 | 737 |
| OPM % | 26% | 24% | 24% |
| Other income | 30 | 27 | 59 |
| Interest | 132 | 289 | 293 |
| Depreciation | 141 | 185 | 187 |
| Profit before tax | 344 | 244 | 315 |
| Tax % | 26% | 24% | 23% |
| Net profit | 254 | 187 | 243 |
| EPS (₹) | 2.17 | 1.51 | 1.96 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Manipal Health Enterprises Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 1,813 | 3,975 | 4,806 | 6,172 | 8,242 | 10,336 |
| Operating profit | 330 | 921 | 1,279 | 1,683 | 2,127 | 2,611 |
| OPM % | 18% | 23% | 27% | 27% | 26% | 25% |
| Net profit | -138 | 542 | 429 | 533 | 1,082 | 917 |
| EPS (₹) | -20.12 | 71.63 | 56.73 | 78.58 | 27.65 | 7.56 |
TTM is the trailing twelve months to the most recent quarter.
Manipal Health Enterprises Ltd balance sheet
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 69 | 76 | 76 | 76 | 77 | 236 |
| Reserves | 1,064 | 2,732 | 3,166 | 3,940 | 5,770 | 8,190 |
| Borrowings | 1,575 | 2,017 | 2,184 | 5,130 | 6,385 | 12,863 |
| Other liabilities | 1,316 | 2,521 | 2,337 | 1,612 | 1,658 | 3,446 |
| Total liabilities | 4,024 | 7,346 | 7,763 | 10,757 | 13,890 | 24,735 |
| Fixed assets | 2,278 | 4,582 | 4,784 | 8,158 | 9,826 | 18,753 |
| CWIP | 412 | 1,089 | 1,033 | 42 | 614 | 795 |
| Investments | 551 | 768 | 1,038 | 1,121 | 1,776 | 2,675 |
| Other assets | 784 | 907 | 908 | 1,436 | 1,675 | 2,511 |
| Total assets | 4,024 | 7,346 | 7,763 | 10,757 | 13,890 | 24,735 |
As reported by the company. Total assets equal total liabilities by construction.
Manipal Health Enterprises Ltd cash flow
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 426 | 805 | 1,149 | 1,389 | 1,570 | 2,078 |
| Cash from investing | -188 | -1,711 | -994 | -846 | -2,544 | -7,025 |
| Cash from financing | -280 | 941 | -144 | -250 | 904 | 4,954 |
| Net cash flow | -42 | 34 | 12 | 293 | -70 | 8 |
| Free cash flow | 334 | 629 | 823 | 1,062 | 520 | 767 |
| CFO / operating profit | 106% | 98% | 105% | 100% | 87% | 96% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Manipal Health Enterprises Ltd operating ratios
| Per year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | — | 18% | 19% | 18% | 16% | 12% |
| Debtor days | 26 | 27 | 24 | 27 | 28 | 33 |
| Inventory days | 20 | 28 | 23 | 30 | 29 | 29 |
| Days payable | 371 | 246 | 283 | 330 | 245 | 253 |
| Cash conversion cycle | -325 | -190 | -236 | -273 | -188 | -190 |
| Working capital days | -95 | -113 | -56 | -58 | -40 | -70 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Manipal Health Enterprises Ltd shareholding pattern
| % held | Aug 2026 |
|---|---|
| Promoters | 72.08% |
| FIIs | 3.66% |
| DIIs | 5.20% |
| Government | 0.26% |
| Public | 18.81% |
| No. of shareholders | 3,38,074 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Manipal Health Enterprises Ltd corporate filings
- Compliance- Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.Company Updatelow impact
- Manipal Health Enterprises' recent AGM disclosures reveal stable financials with significant institutional support, but the approval of key resolutions indicates strategic shifts that could influence investor sentiment.AGM/EGMmedium impact
Cruxal's analysis: Manipal Health Enterprises reported consistent quarterly revenues around INR 2,238-3,091…
Read the full analysis - Shareholder Meeting / Postal Ballot-Outcome of AGMAGM/EGMmedium impact
- Intimation of Closure of Trading Window under SEBI (Prohibition of Insider Trading Regulation, 2015 for the quarter and half year ended September 30, 2026.Insider Trading / SASTlow impact
- Manipal Health Enterprises Ltd releases routine corporate press releaseCompany Updatelow impact
Cruxal's analysis: The company has filed a press release under Regulation 30 of the SEBI (LODR) Regulations…
Read the full analysis - Manipal Health Enterprises Ltd files routine regulatory intimation under SEBI Regulation 30Company Updatelow impact
Cruxal's analysis: The company has submitted a routine disclosure pursuant to Regulation 30(12) read with…
Read the full analysis - Manipal Health Enterprises Limited Announces 16th Annual General Meeting (AGM) for September 29, 2026Company Updatelow impact
Cruxal's analysis: Manipal Health Enterprises Limited has issued a formal intimation regarding its 16th…
Read the full analysis - Manipal Global Health Services discloses promoter encumbrance details under SEBI regulationsInsider Trading / SASTlow impact
Cruxal's analysis: The company filed a disclosure regarding promoter encumbrance under Regulation 31(1) read…
Read the full analysis - Manipal Health Enterprises Limited Promoters Encumber 3.69 crore Shares for INR 500 Crore Debt IssuanceInsider Trading / SASTmedium impact
Cruxal's analysis: Manipal Health Enterprises Limited has disclosed that its promoters have created an…
Read the full analysis - Manipal Health Enterprises Ltd announces 16th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Manipal Health Enterprises Ltd has issued a newspaper publication regarding the…
Read the full analysis - Manipal Health Enterprises Reports Strong Q1 FY27 Growth Driven by Volume and Operational EfficienciesCompany Updatehigh impact
Cruxal's analysis: Manipal Health Enterprises Limited reported a robust Q1 FY27 performance with revenue of…
Read the full analysis - Manipal Health Enterprises Limited uploads audio recording of Q1 FY2027 earnings conference callCompany Updatelow impact
Cruxal's analysis: Manipal Health Enterprises Limited has formally disclosed the audio recording of its…
Read the full analysis - Manipal Health Enterprises Limited Reports Unaudited Financial Results for Quarter Ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Manipal Health Enterprises Limited has formally submitted its un-audited financial…
Read the full analysis - Manipal Health Enterprises Reports Strong Q1 FY27 Revenue Growth of 38.1% YoY, Driven by High-Acuity Specialties and Sahyadri IntegrationCompany Updatehigh impact
Cruxal's analysis: Manipal Health Enterprises Limited delivered a robust performance in its first quarter as…
Read the full analysis - Manipal Health Enterprises Reports Q1 FY27 Results with 14.5% Revenue Growth and Announces Governance RestructuringBoard Meetingmedium impact
Cruxal's analysis: Manipal Health Enterprises Limited reported consolidated revenue of 3,090.63 crore for…
Read the full analysis - Manipal Health Enterprises announces acquisition of Kinder Women's Hospital in BengaluruCompany Updatemedium impact
Cruxal's analysis: Manipal Health Enterprises has announced the acquisition of Kinder Women's Hospital…
Read the full analysis - Manipal Health Enterprises to acquire Kinder Women’s Hospital and Fertility Centre for INR 130 croreCompany Updatemedium impact
Cruxal's analysis: Manipal Health Enterprises Limited has entered into a Business Transfer Agreement to…
Read the full analysis - Manipal Health Enterprises schedules analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Manipal Health Enterprises has issued an intimation regarding a scheduled…
Read the full analysis - Manipal Global Health Services discloses promoter share encumbrance detailsInsider Trading / SASTlow impact
Cruxal's analysis: The exchange received a disclosure on August 14, 2026, regarding the reasons for share…
Read the full analysis - Manipal Health Enterprises Limited Discloses Extensive Promoter Share Encumbrances and Debt CovenantsInsider Trading / SASThigh impact
Cruxal's analysis: Manipal Health Enterprises Limited has filed a disclosure under SEBI (Substantial…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.